English
French
German
Italian
Russian
Spanish
Portuguese
Dutch
Greek
Japanese
Korean
Home ProductsLegal Oral Steroids

Raloxifene Hydrochloride Legal Oral Steroids CAS 82640-04-8 Keoxifene Powder Anti Cancer

Send Me The Latest Product Alerts
(No SPAM - We would not sell or share your e-mail address.)

Raloxifene Hydrochloride Legal Oral Steroids CAS 82640-04-8 Keoxifene Powder Anti Cancer

Good Quality Raloxifene Hydrochloride Legal Oral Steroids CAS 82640-04-8 Keoxifene Powder Anti Cancer Sales

Large Image :  Raloxifene Hydrochloride Legal Oral Steroids CAS 82640-04-8 Keoxifene Powder Anti Cancer

zhuhai TianJian Chemical Co.,Ltd.

Verified Supplier

ZHUHAI

Business type: Manufacturer

Telephone : 86--18928065686

Rm. 804, 1st Building, No. 101, Guofang Road, Gongbei, Zhuhai, Guangdong, China

Product Details:

Place of Origin: ZHUHAI
Brand Name: TJ STEROIDS
Certification: SGS
Model Number: TJ STEROIDS

Payment & Shipping Terms:

Minimum Order Quantity: 10G
Price: Negotiate
Packaging Details: Camouflage package
Delivery Time: prompt after payment
Payment Terms: Western Union, MoneyGram, T/T
Supply Ability: Bulk stock
Detailed Product Description
Name: Raloxifene Hydrochloride Assay: 99%
CAS NO: 82640-04-8 MF: C28H28ClNO4S

Detailed Product Description
Product Name: Raloxifene Hydrochloride Synonym: Keoxifene Hydrochloride , Keoxifene HCL
Assay: 99% Ref. Standard: USP
CAS: 82640-04-8 Appearance light yellow powder
Sky: lmysteriod100

 

 

Production:

Name:raloxifene hcl, Raloxifene hydrochloride

CAS No.:82640-04-8

MF:C28H28ClNO4S

Use:antineoplastic

Appearance:light yellow powder

 

Application:

1. OverView:
Evista (Raloxifene Hydrochloride) is an estrogen agonist/antagonist, referred to as a selective estrogen receptor modulator (SERM) and belongs to the benzothiophene class of compounds. The biological actions of Raloxifene are largely mediated through binding to estrogen receptors. This binding results in activation of estrogenic pathways in some tissues (Agonism) and and the blockade of estrogenic pathways in other tissues (Antagonism).

 

2. Why is this medication prescribed:

(1) Raloxifene is used to prevent and treat osteoporosis (condition in which the bones become thin and weak and break easily) in women who have undergone menopause (change of life; end of menstrual periods). Raloxifene is also used to decrease the risk of developing invasive breast cancer (breast cancer that has spread outside of the milk ducts or lobules into the surrounding breast tissue) in women who are at high risk of developing this type of cancer or who have osteoporosis. Raloxifene cannot be used to treat invasive breast cancer or to prevent invasive breast cancer from coming back in women who have already had the condition. 
(2) Raloxifene also cannot be used to decrease the risk of developing non-invasive breast cancer. Raloxifene is in a class of medications called selective estrogen receptor modulators (SERMs). Raloxifene prevents and treats osteoporosis by mimicking the effects of estrogen (a female hormone produced by the body) to increase the density (thickness) of bone. Raloxifene decreases the risk of developing invasive breast cancer by blocking the effects of estrogen on breast tissue. This may stop the development of tumors that need estrogen to grow.

 

3. Use and Dose:
Evista is specifically approved for the treatment and prevention of osteoporosis in postmenopausal women, the reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis and the reduction in risk of invasive breast cancer in postmenopausal women at high risk of invasive breast cancer. Evista is supplied as a 60 mg tablet designed for oral administration. The recommended initial dose of the drug is one 60 mg tablet daily, which may be administered any time of day without regard to meals.

 

 

Specification:

 

Product Name:

Raloxifene hydrochloride

CAS:

82640-04-8

MF:

C28H28ClNO4S

MW:

510.04

Product Categories:

Active Pharmaceutical Ingredients;Raloxifene;
Intracellular receptor;Aromatics;Intermediates &

Fine Chemicals;Pharmaceuticals;Sulfur &

Selenium Compounds;Pharmaceutical

intermediate

Mol File:

82640-04-8.mol

mp

250-253°C

storage temp.

-20°C Freezer

solubility

DMSO: 28 mg/mL, soluble

form

solid

color

light yellow

CAS DataBase Reference

82640-04-8(CAS DataBase Reference)

Chemical Properties

Light-Yellow Solid

Usage

A nonsteroidal, selective estrogen receptor

modulator (SERM). Antiosteoporotic.

 

Raloxifene Hydrochloride Legal Oral Steroids CAS 82640-04-8 Keoxifene Powder Anti Cancer

OUR ADWANTAGE: 
1, High quality with competitive price: 
1) Standard: Enterprise Standard
2) All Purity≥98%
3) We are manufacturer and can provide high quality products with factory price. 
2, Fast and safe delivery
1) Parcel can be sent out within 24 hours after payment. Tracking number available
2) Secure and discreet shipment. Various transportation methods for your choice. 
3) Customs pass rate ≥99%
4) We have our own agent/remailer/distributor who can help us ship our products very fast and safe, and we have stock in there for transferring. 
3, We have clients throughout the world. 
1) Professional service and rich experience make customers feel at ease, adequate stock and fast delivery meet their desire. 
2) Market feedback and goods feedback will be appreciated, meeting customers's requirement is our responsibility. 
3) High quality, competitive price, fast delivery, first-class service gain the trust and praise from the customers. Raloxifene Hydrochloride Legal Oral Steroids CAS 82640-04-8 Keoxifene Powder Anti Cancer

Contact Details
China Chemical Online Marketplace

Send your inquiry directly to us (0 / 3000)